Log In
BCIQ
Print this Print this
 

CGEN-15049

  Manage Alerts
Collapse Summary General Information
Company Compugen Ltd.
DescriptionB7/CD28-like membrane protein
Molecular Target
Mechanism of ActionImmunotherapy; Antibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/18/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today